silver has been researched along with Disease, Pulmonary in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| A Pinto, TJ; Chellappan, DK; Dua, K; Gupta, G; Jha, NK; Löbenberg, R; MacLoughlin, R; Prasher, P; Sharma, M; Singh, SK | 1 |
| Babaie, P; Hasanzadeh, M; Jouyban, A; Jouyban-Gharamaleki, V | 1 |
| Hasanzadeh, M; Jafari, M; Jouyban, A; Jouyban-Gharamaleki, V; Shadjou, N; Solhi, E; Tagi, S | 1 |
| Chen, CY; Liao, CM; Lu, TH; Wang, WM; Yang, YF | 1 |
| Banlunara, W; Ekgasit, S; Kaewamatawong, T; Maneewattanapinyo, P; Thammachareon, C | 1 |
| Chung, KH; Kim, HR; Oh, SM; Park, CW; Park, YJ; Shin, DY | 1 |
| Porter, AE; Ryan, MP; Tetley, TD; Theodorou, IG | 1 |
| Cannon, CL; Cho, S; Li, R; Raymond, JE; Shah, PN; Smolen, JA; Wang, H; Wooley, KL; Zhang, F; Zhang, S | 1 |
| Che, B; Dong, G; Luo, Q; Wang, J; Xin, L; Zhang, LW | 1 |
| HARDING, HE | 1 |
| BARRIE, HJ; HARDING, HE | 1 |
| Chang, HK; Cho, MH; Chung, YH; Han, BS; Han, JH; Jeon, KS; Jeong, J; Ji, JH; Kelman, BJ; Kim, DS; Lee, JH; Park, JD; Song, MY; Sung, JH; Yoon, JU; Yu, IJ | 1 |
| Chang, HK; Chung, YH; Han, BS; Han, JH; Jeong, J; Ji, JH; Kim, DS; Kim, J; Kim, TS; Lee, EJ; Lee, JH; Song, MY; Sung, JH; Yoon, JU; Yu, IJ | 1 |
| Barnes, WG; Brandsberg, JW; Brugger, NH; Hodges, GR; Lee, SH; McGregor, DH | 1 |
| Brooks, SM | 1 |
| Jacobs, I; Rosenman, KD; Seixas, N | 1 |
| Tateishi, R | 1 |
| Brendel, W; Guthy, E | 1 |
4 review(s) available for silver and Disease, Pulmonary
| Article | Year |
|---|---|
Advanced drug delivery systems targeting NF-κB in respiratory diseases.
Topics: Animals; Biocompatible Materials; Drug Delivery Systems; Humans; Lung Diseases; Metal Nanoparticles; NF-kappa B; Polymers; Silver | 2021 |
Inhalation of silver nanomaterials--seeing the risks.
Topics: Animals; Ecotoxicology; Humans; Inhalation Exposure; Lung Diseases; Nanostructures; Risk; Silver | 2014 |
Lung disorders resulting from the inhalation of metals.
Topics: Aluminum; Antimony; Barium; Cobalt; Humans; Iron; Lung Diseases; Metals; Metals, Rare Earth; Occupational Diseases; Silver; Tin; Tungsten; Tungsten Compounds; Zirconium | 1981 |
Stapling devices and their use in surgery.
Topics: Adult; Bronchial Fistula; Child; Esophagus; Gastrectomy; Humans; Jejunum; Lung Diseases; Neurosurgery; Postoperative Complications; Silver; Sternum; Stomach; Surgical Staplers; Suture Techniques; Sutures; Tantalum; Thoracic Surgery; Thorax; Tuberculosis; Vascular Surgical Procedures | 1969 |
14 other study(ies) available for silver and Disease, Pulmonary
| Article | Year |
|---|---|
The use of chitosan as a bioactive polysaccharide in non-invasive detection of malondialdehyde biomarker in human exhaled breath condensate: A new platform towards diagnosis of some lung disease.
Topics: Biomarkers; Biosensing Techniques; Breath Tests; Chitosan; Electrodes; Exhalation; Humans; Indoles; Lung Diseases; Malondialdehyde; Metal Nanoparticles; Polymers; Silver | 2018 |
Non-invasive quantification of malondialdehyde biomarker in human exhaled breath condensate using self-assembled organic-inorganic nanohybrid: A new platform for early diagnosis of lung disease.
Topics: Biocompatible Materials; Biomarkers; Breath Tests; Carbon; Early Diagnosis; Electrochemical Techniques; Electrodes; Graphite; Healthy Volunteers; Humans; Lung Diseases; Malondialdehyde; Metal Nanoparticles; Microscopy, Electron, Scanning; Nanocomposites; Riboflavin; Sensitivity and Specificity; Silver; Taurine | 2019 |
Assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products.
Topics: Administration, Inhalation; Aerosols; Animals; Environmental Exposure; Humans; Lung; Lung Diseases; Metal Nanoparticles; Models, Theoretical; Particle Size; Rats; Risk Assessment; Silver | 2019 |
Acute and subacute pulmonary toxicity caused by a single intratracheal instillation of colloidal silver nanoparticles in mice: pathobiological changes and metallothionein responses.
Topics: Acute Disease; Administration, Inhalation; Animals; Colloids; Disease Models, Animal; Epithelial Cells; Lung; Lung Diseases; Macrophages; Male; Metal Nanoparticles; Metallothionein; Mice; Mice, Inbred ICR; Silver; Time Factors | 2014 |
Silver nanoparticles induce p53-mediated apoptosis in human bronchial epithelial (BEAS-2B) cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; Bronchi; Caspase 3; Cells, Cultured; DNA Fragmentation; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Lung Diseases; Metal Nanoparticles; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Silver; Toluene; Tumor Suppressor Protein p53 | 2014 |
Degradable polyphosphoester-based silver-loaded nanoparticles as therapeutics for bacterial lung infections.
Topics: Acetates; Anti-Bacterial Agents; Bacterial Infections; Biocompatible Materials; Bronchi; Cations; Cystic Fibrosis; Drug Delivery Systems; Drug Design; Epithelial Cells; Humans; Lung Diseases; Metal Nanoparticles; Micelles; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Nanotechnology; Polymers; Silver; Silver Compounds; Solubility; Spectrum Analysis, Raman; Water | 2015 |
Comparative genotoxicity of silver nanoparticles in human liver HepG2 and lung epithelial A549 cells.
Topics: A549 Cells; Cell Cycle Proteins; Cell Survival; Chemical and Drug Induced Liver Injury; DNA Damage; Dose-Response Relationship, Drug; Epithelial Cells; Hep G2 Cells; Humans; Liver; Lung; Lung Diseases; Metal Nanoparticles; Mutagenicity Tests; Nuclear Proteins; Silver | 2017 |
Fibrosis in the lungs of a silver finisher.
Topics: Humans; Industry; Lung; Lung Diseases; Occupational Diseases; Occupations; Silver; Silver Compounds | 1948 |
Argyro-siderosis of the lungs in silver finishers.
Topics: Humans; Industry; Lung; Lung Diseases; Occupational Diseases; Occupations; Siderosis; Silver | 1947 |
Subchronic inhalation toxicity of silver nanoparticles.
Topics: Animals; Blood Chemical Analysis; Body Weight; Dose-Response Relationship, Drug; Eating; Erythrocyte Aggregation; Female; Inhalation Exposure; Kidney Function Tests; Lung Diseases; Male; Nanoparticles; Organ Size; Particle Size; Pneumonia; Rats; Rats, Sprague-Dawley; Sex Characteristics; Silver | 2009 |
Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles.
Topics: Animals; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Inflammation; Inhalation Exposure; Lung; Lung Diseases; Male; Metal Nanoparticles; Rats; Rats, Sprague-Dawley; Respiratory Function Tests; Silver | 2008 |
Misdiagnosis caused by fungal contaminant in a histological stain solution.
Topics: Granuloma; Humans; Lung Diseases; Male; Middle Aged; Mitosporic Fungi; Mycoses; Silver; Staining and Labeling | 1980 |
Potential nephrotoxic effects of exposure to silver.
Topics: Acetylglucosaminidase; Cadmium; Creatinine; Humans; Kidney; Kidney Diseases; Lung Diseases; Occupational Diseases; Silver; Vision, Ocular | 1987 |
Distribution of argyrophil cells in adult human lungs.
Topics: Adult; Aged; Basement Membrane; Bronchi; Epithelial Cells; Female; Humans; Hyperplasia; Lung; Lung Diseases; Male; Metaplasia; Middle Aged; Silver; Staining and Labeling | 1973 |